Toxoplasma Gondii Dna

• USES: • For the temporary relief of symptoms including: • body aches • headache • fever • fatigue These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R51.9

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

Recent PubMed references pinned to Toxoplasma Gondii Dna as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Toxoplasma gondii effector MAF1 blocks mouse AIM2 inflammasome activation by inhibiting mtDNA release.
  Journal of immunology (Baltimore, Md. : 1950) · 2026 · Zhao XY, Holness NK, Lempke SL, et al.
  PMID 41764738DOI 10.1093/jimmun/vkaf360
• Low-volume multiplex solid-phase PCR without DNA extraction for etiological diagnosis of infectious uveitis.
  Indian journal of ophthalmology · 2026 · Ferracioli-Oda E, Tanaka T, Gouvea MSG, et al.
  PMID 41581039DOI 10.4103/IJO.IJO_1135_25
• Molecular detection of Toxoplasma gondii in paraffin blocks from patients diagnosed with various cancers.
  Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025 · Pourahmad A, Shirazi Yeganeh B, Abdoli A, et al.
  PMID 40820702DOI 10.1093/trstmh/traf083
• First Molecular Detection of Toxoplasma gondii DNA in Blood and Milk of Goats from Algeria.
  Pathogens (Basel, Switzerland) · 2025 · Dahmane A, Vismarra A, Passebosc-Faure K, et al.
  PMID 40005549DOI 10.3390/pathogens14020174
• Comparative evaluation of funduscopy, PCR and serology in the diagnosis of ocular toxoplasmosis at ECWA Eye Hospital, Kano.
  BMJ open ophthalmology · 2025 · Adebakin BB, Bala JA, Atima MO, et al.
  PMID 39837789DOI 10.1136/bmjophth-2024-002023
• Efficacy of amniotic fluid, blood and urine samples for the diagnosis of toxoplasmosis in pregnant women candidates for amniocentesis using serological and molecular techniques.
  BMC pregnancy and childbirth · 2024 · Abedian R, Esboei BR, Kordi S, et al.
  PMID 39578753DOI 10.1186/s12884-024-06979-x
• Toxoplasma gondii DNA in Tissues of Anadromous Arctic Charr, Salvelinus alpinus, Collected From Nunavik, Québec, Canada.
  Zoonoses and public health · 2024 · Merks H, Gomes R, Zhu S, et al.
  PMID 39252165DOI 10.1111/zph.13175
• First Report on the Molecular Detection and Genetic Characterization of Toxoplasma gondii From Donkeys in Kenya.
  Acta parasitologica · 2024 · Obonyo FO, Maingi N, Githigia SM, et al.
  PMID 39160342DOI 10.1007/s11686-024-00905-z

The 1 most recently updated of 1 ClinicalTrials.gov registrations naming Toxoplasma Gondii Dna as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Genetic Diversity of Toxoplasma Gondii in Cancer Patients
  Unknown · Observational · 100 enrolled · Sohag University
  NCT04834076updated 2022-01-13

Frequently asked questions

What is Toxoplasma Gondii Dna used for?

According to FDA labeling, Toxoplasma Gondii Dna carries indications including: USES: • For the temporary relief of symptoms including: • body aches • headache • fever • fatigue These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.